Retention periods for records relating to the collection of blood and blood components, the manufacture of blood products and its use

被引:1
|
作者
Hasskarl, Horst [1 ]
Bakhschai, Bita [1 ]
机构
[1] Kanzlei Harms Hasskarl Melzer, D-67061 Ludwigshafen, Germany
关键词
Obligations to archive records; Retention period; Addressees;
D O I
10.1159/000316855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Retention Periods for Documentation Relating to the Collection of Blood and Blood Components, the Manufacture of Blood Products and Their Application The collection of blood and blood components, the manufacture of blood products and the application of blood products has to comply with numerous obligations relating to the documentation and the retention period which are based in the law and recommendations. Addressees of these obligations are inter alia the physician, the blood establishment, the manufacturer, the holder of a marketing authorisation (pharmaceutical entrepreneur) or the sponsor. Practical experience has revealed that it is not easy for the concerned addressees to determine and fulfil the obligations to archive and to preserve the retention period in a reliable manner and to the necessary extent. In the following a practical approach is made to compile the essential retention periods relating to documentations in the field of blood. The essential legal basis concerning the retention period of documentations in the field of blood are cited.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 50 条
  • [1] CLINICAL USE OF BLOOD, BLOOD COMPONENTS AND BLOOD PRODUCTS
    BLAJCHMAN, MA
    SHEPHERD, FA
    PERRAULT, RA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1979, 121 (01) : 33 - &
  • [2] The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products
    Mahony, B. O.
    Turner, A.
    VOX SANGUINIS, 2010, 98 (03) : 447 - 450
  • [3] International blood collection and storage: Clinical use of blood products
    Greening, David W.
    Glenister, Kristen M.
    Sparrow, Rosemary L.
    Simpson, Richard J.
    JOURNAL OF PROTEOMICS, 2010, 73 (03) : 386 - 395
  • [4] New guidelines on the harvesting of blood and blood components and on the use of blood products (hemotherapy)
    Biscoping, J
    Schlegel, E
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2000, 41 (09): : 709 - 711
  • [5] USE OF BLOOD AND BLOOD COMPONENTS
    SHAFER, AW
    SOUTHERN MEDICAL JOURNAL, 1975, 68 (05) : 631 - 634
  • [6] Use of blood and blood products
    Hunt, E
    Wood, B
    VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 1999, 15 (03) : 641 - +
  • [7] USE OF BLOOD AND BLOOD PRODUCTS
    HUNT, E
    MOORE, JS
    VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 1990, 6 (01) : 133 - 147
  • [8] MANUFACTURE OF HUMAN BLOOD PRODUCTS
    ZUCKERMA.L
    TRANSACTIONS OF THE NEW YORK ACADEMY OF SCIENCES, 1972, 34 (06): : 558 - &
  • [9] RATIONAL USE OF BLOOD AND BLOOD COMPONENTS
    VIELE, MK
    DONEGAN, EA
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1992, 25 (06) : 1321 - 1339
  • [10] COLLECTION, TESTING AND USE OF BLOOD AND BLOOD COMPONENTS IN EUROPE (REVIEW OF THE DATA OF THE EUROPEAN COUNCIL)
    Nikitin, I. K.
    Thay, S. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2011, 56 (06): : 39 - 44